190 related articles for article (PubMed ID: 32106855)
1. Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes.
Jörns A; Ishikawa D; Teraoku H; Yoshimoto T; Wedekind D; Lenzen S
BMC Med; 2020 Feb; 18(1):33. PubMed ID: 32106855
[TBL] [Abstract][Full Text] [Related]
2. Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat.
Jörns A; Arndt T; Yamada S; Ishikawa D; Yoshimoto T; Terbish T; Wedekind D; van der Meide PH; Lenzen S
J Mol Med (Berl); 2020 Aug; 98(8):1125-1137. PubMed ID: 32607871
[TBL] [Abstract][Full Text] [Related]
3. Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes.
Jörns A; Akin M; Arndt T; Terbish T; Zu Vilsendorf AM; Wedekind D; Hedrich HJ; Lenzen S
J Mol Med (Berl); 2014 Jul; 92(7):743-55. PubMed ID: 24599515
[TBL] [Abstract][Full Text] [Related]
4. TNF-α Antibody Therapy in Combination With the T-Cell-Specific Antibody Anti-TCR Reverses the Diabetic Metabolic State in the LEW.1AR1-iddm Rat.
Jörns A; Ertekin ÜG; Arndt T; Terbish T; Wedekind D; Lenzen S
Diabetes; 2015 Aug; 64(8):2880-91. PubMed ID: 25784545
[TBL] [Abstract][Full Text] [Related]
5. Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes.
Arndt T; Wedekind D; Weiss H; Tiedge M; Lenzen S; Hedrich HJ; Jörns A
Diabetologia; 2009 Jul; 52(7):1381-90. PubMed ID: 19367386
[TBL] [Abstract][Full Text] [Related]
6. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.
Jörns A; Arndt T; Meyer zu Vilsendorf A; Klempnauer J; Wedekind D; Hedrich HJ; Marselli L; Marchetti P; Harada N; Nakaya Y; Wang GS; Scott FW; Gysemans C; Mathieu C; Lenzen S
Diabetologia; 2014 Mar; 57(3):512-21. PubMed ID: 24310561
[TBL] [Abstract][Full Text] [Related]
7. Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1
Baskal S; Tsikas SA; Begou O; Bollenbach A; Lenzen S; Jörns A; Tsikas D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163462
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric dimethylation and citrullination in the LEW.1AR1-iddm rat, an animal model of human type 1 diabetes, and effects of anti-TCR/anti-TNF-α antibody-based therapy.
Bollenbach A; Tsikas D; Lenzen S; Jörns A
Amino Acids; 2020 Jan; 52(1):103-110. PubMed ID: 31832896
[TBL] [Abstract][Full Text] [Related]
9. Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat.
Jörns A; Günther A; Hedrich HJ; Wedekind D; Tiedge M; Lenzen S
Diabetes; 2005 Jul; 54(7):2041-52. PubMed ID: 15983205
[TBL] [Abstract][Full Text] [Related]
10. Effects of polyinosinic-polycytidylic acid and adoptive transfer of immune cells in the Lew.1AR1-iddm rat and in its coisogenic LEW.1AR1 background strain.
Wedekind D; Weiss H; Jörns A; Lenzen S; Tiedge M; Hedrich HJ
Autoimmunity; 2005 Jun; 38(4):265-75. PubMed ID: 16206509
[TBL] [Abstract][Full Text] [Related]
11. Variable immune cell frequencies in peripheral blood of LEW.1AR1-iddm rats over time compared to other congenic LEW strains.
Arndt T; Jörns A; Hedrich HJ; Lenzen S; Wedekind D
Clin Exp Immunol; 2014 Jul; 177(1):168-78. PubMed ID: 24628466
[TBL] [Abstract][Full Text] [Related]
12. Changes in immune cell frequencies in primary and secondary lymphatic organs of LEW.1AR1-iddm rats, a model of human type 1 diabetes compared to other MHC congenic LEW inbred strains.
Arndt T; Jörns A; Wedekind D
Immunol Res; 2018 Aug; 66(4):462-470. PubMed ID: 30143971
[TBL] [Abstract][Full Text] [Related]
13. Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet.
Crookshank JA; Patrick C; Wang GS; Noel JA; Scott FW
Immunology; 2015 Jul; 145(3):417-28. PubMed ID: 25711680
[TBL] [Abstract][Full Text] [Related]
14. A variable CD3⁺ T-cell frequency in peripheral blood lymphocytes associated with type 1 diabetes mellitus development in the LEW.1AR1-iddm rat.
Arndt T; Jörns A; Weiss H; Tiedge M; Hedrich HJ; Lenzen S; Wedekind D
PLoS One; 2013; 8(5):e64305. PubMed ID: 23717591
[TBL] [Abstract][Full Text] [Related]
15. The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus).
Peschke E; Hofmann K; Bähr I; Streck S; Albrecht E; Wedekind D; Mühlbauer E
Diabetologia; 2011 Jul; 54(7):1831-40. PubMed ID: 21491159
[TBL] [Abstract][Full Text] [Related]
16. Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation.
Jörns A; Rath KJ; Terbish T; Arndt T; Meyer Zu Vilsendorf A; Wedekind D; Hedrich HJ; Lenzen S
Endocrinology; 2010 Aug; 151(8):3555-65. PubMed ID: 20501676
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of the LEW.1AR1-iddm rat: an animal model for spontaneous diabetes mellitus.
Weiss H; Bleich A; Hedrich HJ; Kölsch B; Elsner M; Jörns A; Lenzen S; Tiedge M; Wedekind D
Mamm Genome; 2005 Jun; 16(6):432-41. PubMed ID: 16075370
[TBL] [Abstract][Full Text] [Related]
18. The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus.
Lenzen S; Tiedge M; Elsner M; Lortz S; Weiss H; Jörns A; Klöppel G; Wedekind D; Prokop CM; Hedrich HJ
Diabetologia; 2001 Sep; 44(9):1189-96. PubMed ID: 11596676
[TBL] [Abstract][Full Text] [Related]
19. Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes.
Lenzen S
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28692149
[TBL] [Abstract][Full Text] [Related]
20. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
